Related references
Note: Only part of the references are listed.Identification of key genes associated with polycystic ovary syndrome (PCOS) and ovarian cancer using an integrated bioinformatics analysis
Juan Zou et al.
JOURNAL OF OVARIAN RESEARCH (2022)
Case Report of Small Cell Carcinoma of the Ovary, Hypercalcemic Type (Ovarian Rhabdoid Tumor) with SMARCB1 Mutation: A Literature Review of a Rare and Aggressive Condition
Maria Fernanda Evangelista Simoes et al.
CURRENT ONCOLOGY (2022)
Inflammatory Cytokines in Cancer: Comprehensive Understanding and Clinical Progress in Gene Therapy
Tianxia Lan et al.
CELLS (2021)
A bond between rheumatic diseases and cancer in the elderly: The interleukin-6 pathway
Giuseppe Carlo Iorio et al.
INTERNATIONAL JOURNAL OF RHEUMATIC DISEASES (2021)
Association of leptin G2548A and leptin receptor Q223R polymorphisms and their serum levels with infertility and recurrent pregnancy loss in Iranian women with polycystic ovary syndrome
Fatemeh Bagheri Kargasheh et al.
PLOS ONE (2021)
Endometriosis-associated ovarian cancer occurs early during follow-up of endometrial cysts
Kosuke Murakami et al.
INTERNATIONAL JOURNAL OF CLINICAL ONCOLOGY (2020)
Endometriosis and risk of ovarian cancer: what do we know?
Milena Kralickova et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2020)
Environmental toxin exposure in polycystic ovary syndrome women and possible ovarian neoplastic repercussion
Ilaria Soave et al.
CURRENT MEDICAL RESEARCH AND OPINION (2020)
The polycystic ovary syndrome and gynecological cancer risk
Blazej Meczekalski et al.
GYNECOLOGICAL ENDOCRINOLOGY (2020)
Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review
Liudmila M. Mikhaleva et al.
ADVANCES IN THERAPY (2020)
Epigenetic Attire in Ovarian Cancer: The Emperor's New Clothes
Daniela Matei et al.
CANCER RESEARCH (2020)
miR-155 is high-expressed in polycystic ovarian syndrome and promotes cell proliferation and migration through targeting PDCD4 in KGN cells
Huanjun Xia et al.
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY (2020)
miRNA profile in ovarian cancer
Soudeh Ghafouri-Fard et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2020)
Stereotactic body radiation therapy in the treatment of ovarian cancer
Roman O. Kowalchuk et al.
RADIATION ONCOLOGY (2020)
Downregulation of Lnc-OC1 attenuates the pathogenesis of polycystic ovary syndrome
Gengxiang Wu et al.
MOLECULAR AND CELLULAR ENDOCRINOLOGY (2020)
The clinical impact of intra- and extracellular miRNAs in ovarian cancer
Kosuke Yoshida et al.
CANCER SCIENCE (2020)
Small Cell Carcinoma of the Ovary, Hypercalcemic Type (SCCOHT) beyond SMARCA4 Mutations: A Comprehensive Genomic Analysis
Aurelie Auguste et al.
CELLS (2020)
Endocrine-Disrupting Chemicals and Insulin Resistance in Children
Eleonora Rotondo et al.
BIOMEDICINES (2020)
Oncology and Pharmacogenomics Insights in Polycystic Ovary Syndrome: An Integrative Analysis
Veronica Yumiceba et al.
FRONTIERS IN ENDOCRINOLOGY (2020)
Stereotactic Body Radiation Therapy: A Versatile, Well-Tolerated, and Effective Treatment Option for Extracranial Metastases From Primary Ovarian and Uterine Cancer
Nima Aghdam et al.
FRONTIERS IN ONCOLOGY (2020)
Estrogen Receptor, Progesterone Receptor, and HER2 Receptor Markers in Endometrial Cancer
Caifeng Wang et al.
JOURNAL OF CANCER (2020)
Epithelial ovarian cancer
Stephanie Lheureux et al.
LANCET (2019)
Genetic and epigenetic characteristics in ovarian tissues from polycystic ovary syndrome patients with irregular menstruation resemble those of ovarian cancer
Jiao Jiao et al.
BMC ENDOCRINE DISORDERS (2019)
Estrogen Signaling in Endometrial Cancer: a Key Oncogenic Pathway with Several Open Questions
Adriana C. Rodriguez et al.
HORMONES & CANCER (2019)
Endocrine Disrupting Chemicals: Effects on Endocrine Glands
Rosa Lauretta et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
Ovarian Cancer: An Integrated Review
Christine Stewart et al.
SEMINARS IN ONCOLOGY NURSING (2019)
Polypoid endometriosis - A rare entity of endometriosis mimicking ovarian cancer
Cleo Tsai et al.
TAIWANESE JOURNAL OF OBSTETRICS & GYNECOLOGY (2019)
Circulating miRNAs as Biomarkers for Endometriosis and Endometriosis-Related Ovarian CancerAn Overview
Marius Alexandru Moga et al.
JOURNAL OF CLINICAL MEDICINE (2019)
Endometriosis-associated ovarian cancer: What have we learned so far?
M. Herreros-Villanueva et al.
CLINICA CHIMICA ACTA (2019)
The role of MiRNA in polycystic ovary syndrome (PCOS)
Baiqi Chen et al.
GENE (2019)
The role of radiotherapy in epithelial ovarian cancer: a literature overview
Giuseppe Carlo Iorio et al.
MEDICAL ONCOLOGY (2019)
Epigenetic Biomarkers in the Management of Ovarian Cancer: Current Prospectives
Alka Singh et al.
FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY (2019)
Interplay Between MicroRNAs and Oxidative Stress in Ovarian Conditions with a Focus on Ovarian Cancer and Endometriosis
Josep Mari-Alexandre et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Ovarian Cancer Genetics and Implications for Imaging and Therapy
Sherif B. Elsherif et al.
JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY (2019)
Epigenetic therapy for ovarian cancer: promise and progress
Sara Moufarrij et al.
CLINICAL EPIGENETICS (2019)
Prognostic importance of atypical endometriosis with architectural hyperplasia versus cytologic atypia in endometriosis-associated ovarian cancer
Isabel Niguez Sevilla et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2019)
Epithelial Mutations in Endometriosis: Link to Ovarian Cancer
Serdar E. Bulun et al.
ENDOCRINOLOGY (2019)
miRNAs and ovarian cancer: An overview
Bornali Deb et al.
JOURNAL OF CELLULAR PHYSIOLOGY (2018)
Ovarian Cancer: A Heterogeneous Disease
Myriam Kossai et al.
PATHOBIOLOGY (2018)
Effects of Endocrine-Disrupting Chemicals and Epigenetic Modifications in Ovarian Cancer: A Review
Ratika Samtani et al.
REPRODUCTIVE SCIENCES (2018)
Epigenetics in ovarian cancer
Yanina Natanzon et al.
SEMINARS IN CANCER BIOLOGY (2018)
Five Hypermethylated MicroRNA Genes as Potential Markers of Ovarian Cancer
E. A. Braga et al.
BULLETIN OF EXPERIMENTAL BIOLOGY AND MEDICINE (2018)
Linking type 2 diabetes and gynecological cancer: an introductory overview
Emanuela Anastasi et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2018)
Diagnostic and Prognostic Biomarkers in ovarian cancer and the potential roles of cancer stem cells - An updated review
Thingreila Muinao et al.
EXPERIMENTAL CELL RESEARCH (2018)
Hyperglycemia promotes insulin-independent ovarian tumor growth
Lisa D. Kellenberger et al.
GYNECOLOGIC ONCOLOGY (2018)
Clinical outcomes of patients with clear cell and endometrioid ovarian cancer arising from endometriosis
E. Sun Paik et al.
JOURNAL OF GYNECOLOGIC ONCOLOGY (2018)
A Ketogenic Diet Reduces Central Obesity and Serum Insulin in Women with Ovarian or Endometrial Cancer
Caroline W. Cohen et al.
JOURNAL OF NUTRITION (2018)
Postprandial increase in serum CA125 as a surrogate biomarker for early diagnosis of ovarian cancer
Zhuowei Gu et al.
JOURNAL OF TRANSLATIONAL MEDICINE (2018)
Epigenetic modification of alpha-N-acetylgalactosaminidase enhances cisplatin resistance in ovarian cancer
Ye-Na Ha et al.
KOREAN JOURNAL OF PHYSIOLOGY & PHARMACOLOGY (2018)
Polycystic ovary syndrome: definition, aetiology, diagnosis and treatment
Hector F. Escobar-Morreale
NATURE REVIEWS ENDOCRINOLOGY (2018)
Ovarian Cancer Prevention and Screening
Usha Menon et al.
OBSTETRICS AND GYNECOLOGY (2018)
Risk of Gynecologic Cancer According to the Type of Endometriosis
Liisu Saavalainen et al.
OBSTETRICS AND GYNECOLOGY (2018)
Factors that Differentiate between Endometriosis-associated Ovarian Cancer and Benign Ovarian Endometriosis with Mural Nodules
Yasuhito Tanase et al.
MAGNETIC RESONANCE IN MEDICAL SCIENCES (2018)
Endometriosis-Associated Ovarian Cancer Population Characteristics and Prognosis
Amilcar Barreta et al.
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER (2018)
Epigenetics in ovarian cancer: premise, properties, and perspectives
Qilian Yang et al.
MOLECULAR CANCER (2018)
Association between polycystic ovarian syndrome and endometrial, ovarian, and breast cancer A population-based cohort study in Taiwan
Dah-Ching Ding et al.
MEDICINE (2018)
Impact of diabetes mellitus on epithelial ovarian cancer survival
Setareh Akhavan et al.
BMC CANCER (2018)
Endometriosis and endometriosis-associated cancers: new insights into the molecular mechanisms of ovarian cancer development
Amy Dawson et al.
ECANCERMEDICALSCIENCE (2018)
Long and irregular menstrual cycles, polycystic ovary syndrome, and ovarian cancer risk in a population-based case-control study
H. R. Harris et al.
INTERNATIONAL JOURNAL OF CANCER (2017)
Role of the PI3K-Akt Signaling Pathway in the Pathogenesis of Polycystic Ovary Syndrome
Tiantian Li et al.
REPRODUCTIVE SCIENCES (2017)
TP53 Mutations in Breast and Ovarian Cancer
Laxmi Silwal-Pandit et al.
COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2017)
Ovarian cancer: epidemiology and risk factors
Carlo La Vecchia
EUROPEAN JOURNAL OF CANCER PREVENTION (2017)
Genetics of polycystic ovary syndrome
Kateryna Mykhalchenko et al.
EXPERT REVIEW OF MOLECULAR DIAGNOSTICS (2017)
Epigenetic regulation of RGS2 (Regulator of G-protein signaling 2) in chemoresistant ovarian cancer cells
Ercan Cacan
JOURNAL OF CHEMOTHERAPY (2017)
Cancer Implications for Patients with Endometriosis
Mary Ann Wilbur et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2017)
Epidemiology of ovarian cancer: a review
Brett M. Reid et al.
CANCER BIOLOGY & MEDICINE (2017)
Radiation Treatment in Women with Ovarian Cancer: Past, Present, and Future
Emma C. Fields et al.
FRONTIERS IN ONCOLOGY (2017)
The disparate origins of ovarian cancers: pathogenesis and prevention strategies
Anthony N. Karnezis et al.
NATURE REVIEWS CANCER (2017)
The new classifications of ovarian, fallopian tube, and primary peritoneal cancer and their clinical implications
L. R. Duska et al.
ANNALS OF ONCOLOGY (2017)
IGF system targeted therapy: Therapeutic opportunities for ovarian cancer
J. A. L. Liefers-Visser et al.
CANCER TREATMENT REVIEWS (2017)
Epigenetic regulation of the pathological process in endometriosis
Kuei-Yang Hsiao et al.
REPRODUCTIVE MEDICINE AND BIOLOGY (2017)
Ovarian cancer: Novel molecular aspects for clinical assessment
Raffaele Palmirotta et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
Insulin and the polycystic ovary syndrome
Djuro Macut et al.
DIABETES RESEARCH AND CLINICAL PRACTICE (2017)
Characterization of MicroRNA-200 pathway in ovarian cancer and serous intraepithelial carcinoma of fallopian tube
Junzheng Yang et al.
BMC CANCER (2017)
Hereditary Ovarian Cancer and Risk Reduction
Lesley Andrews et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)
Epidemiology of epithelial ovarian cancer
Penelope M. Webb et al.
BEST PRACTICE & RESEARCH CLINICAL OBSTETRICS & GYNAECOLOGY (2017)
Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
Haller J. Smith et al.
GYNECOLOGIC ONCOLOGY REPORTS (2017)
Pathogenesis and heterogeneity of ovarian cancer
Paul T. Kroeger et al.
CURRENT OPINION IN OBSTETRICS & GYNECOLOGY (2017)
Diabetes mellitus and gynecologic cancer: molecular mechanisms, epidemiological, clinical and prognostic perspectives
Nikolaos Vrachnis et al.
ARCHIVES OF GYNECOLOGY AND OBSTETRICS (2016)
Epigenetic regulation of glycosylation and the impact on chemo-resistance in breast and ovarian cancer
Gordon Greville et al.
EPIGENETICS (2016)
Ovarian cancer in Lynch syndrome; a systematic review
J. M. Helder-Woolderink et al.
EUROPEAN JOURNAL OF CANCER (2016)
Genetic determinants of polycystic ovary syndrome: progress and future directions
Michelle R. Jones et al.
FERTILITY AND STERILITY (2016)
Estrogen-progestins and progestins for the management of endometriosis
Paolo Vercellini et al.
FERTILITY AND STERILITY (2016)
The epigenomics of polycystic ovarian syndrome: from pathogenesis to clinical manifestations
Shuxia Li et al.
GYNECOLOGICAL ENDOCRINOLOGY (2016)
Insulin growth factor (IGF) 1, IGF-binding proteins and ovarian cancer risk: A systematic review and meta-analysis
Ximena Gianuzzi et al.
MATURITAS (2016)
Genetic, hormonal and metabolic aspects of PCOS: an update
V. De Leo et al.
REPRODUCTIVE BIOLOGY AND ENDOCRINOLOGY (2016)
Molecular signatures of ovarian diseases: Insights from network medicine perspective
Medi Kori et al.
SYSTEMS BIOLOGY IN REPRODUCTIVE MEDICINE (2016)
Polycystic ovary syndrome
Ricardo Azziz et al.
NATURE REVIEWS DISEASE PRIMERS (2016)
Hereditary breast and ovarian cancer: new genes in confined pathways
Finn Cilius Nielsen et al.
NATURE REVIEWS CANCER (2016)
AMERICAN ASSOCIATION OF CLINICAL ENDOCRINOLOGISTS, AMERICAN COLLEGE OF ENDOCRINOLOGY, AND ANDROGEN EXCESS AND PCOS SOCIETY DISEASE STATE CLINICAL REVIEW: GUIDE TO THE BEST PRACTICES IN THE EVALUATION AND TREATMENT OF POLYCYSTIC OVARY SYNDROME - PART 1
Neil F. Goodman et al.
ENDOCRINE PRACTICE (2015)
Endometriosis and ovarian cancer: potential benefits and harms of screening and risk-reducing surgery
Sun-Wei Guo
FERTILITY AND STERILITY (2015)
Risk of cancer among women with polycystic ovary syndrome: A Danish cohort study
Mathilde Gottschau et al.
GYNECOLOGIC ONCOLOGY (2015)
The effect of Metformin on endometrial tumor-regulatory genes and systemic metabolic parameters in polycystic ovarian syndrome - a proof-of-concept study
Mohamad Nasir Shafiee et al.
GYNECOLOGICAL ENDOCRINOLOGY (2015)
TP53 oncomorphic mutations predict resistance to platinum- and taxane-based standard chemotherapy in patients diagnosed with advanced serous ovarian carcinoma
Pavla Brachova et al.
INTERNATIONAL JOURNAL OF ONCOLOGY (2015)
Endometriosis and ovarian cancer: links, risks, and challenges faced
Mary Ellen Pavone et al.
INTERNATIONAL JOURNAL OF WOMENS HEALTH (2015)
Arginine methyltransferases mediate an epigenetic ovarian response to endometriosis
Claudia Baumann et al.
REPRODUCTION (2015)
The relation between endometriosis and ovarian cancer - a review
Lene N. Heidemann et al.
ACTA OBSTETRICIA ET GYNECOLOGICA SCANDINAVICA (2014)
PTEN overexpression improves cisplatin-resistance of human ovarian cancer cells through upregulating KRT10 expression
Huijuan Wu et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2014)
The prognostic value of metformin for cancer patients with concurrent diabetes: a systematic review and meta-analysis
Z. -J. Zhang et al.
DIABETES OBESITY & METABOLISM (2014)
Polycystic Ovary Syndrome
Anindita Nandi et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2014)
Two follicle-stimulating hormone receptor polymorphisms and polycystic ovary syndrome risk: a meta-analysis
Dao-Jun Chen et al.
EUROPEAN JOURNAL OF OBSTETRICS & GYNECOLOGY AND REPRODUCTIVE BIOLOGY (2014)
Global distribution pattern of histological subtypes of epithelial ovarian cancer: A database analysis and systematic review
Pi-Lin Sung et al.
GYNECOLOGIC ONCOLOGY (2014)
Mutations in the PTEN tumor gene and risk of endometriosis: a casecontrol study
Suresh Govatati et al.
HUMAN REPRODUCTION (2014)
Metformin in reproductive health, pregnancy and gynaecological cancer: established and emerging indications
Vanitha N. Sivalingam et al.
HUMAN REPRODUCTION UPDATE (2014)
Ovarian and endometrial endometrioid carcinomas have distinct CTNNB1 and PTEN mutation profiles
Melissa K. McConechy et al.
MODERN PATHOLOGY (2014)
Endometriosis: pathogenesis and treatment
Paolo Vercellini et al.
NATURE REVIEWS ENDOCRINOLOGY (2014)
Targeting interleukin-6 in inflammatory autoimmune diseases and cancers
Xin Yao et al.
PHARMACOLOGY & THERAPEUTICS (2014)
Endometrial progesterone resistance and PCOS
Xin Li et al.
JOURNAL OF BIOMEDICAL SCIENCE (2014)
Enhanced tumor suppression by adenoviral PTEN gene therapy combined with cisplatin chemotherapy in small-cell lung cancer
D. Li et al.
CANCER GENE THERAPY (2013)
Clinicopathological correlates and prognostic significance of KRAS mutation status in a pooled prospective cohort of epithelial ovarian cancer
Bjorn Nodin et al.
DIAGNOSTIC PATHOLOGY (2013)
TP53 mutations are common in all subtypes of epithelial ovarian cancer and occur concomitantly with KRAS mutations in the mucinous type
Markus Rechsteiner et al.
EXPERIMENTAL AND MOLECULAR PATHOLOGY (2013)
The Wnt/β-catenin pathway in ovarian cancer: A review
Rebecca C. Arend et al.
GYNECOLOGIC ONCOLOGY (2013)
Is polycystic ovary syndrome, a state of relative estrogen excess, a real risk factor for estrogen-dependant malignancies?
Michael Fanta
GYNECOLOGICAL ENDOCRINOLOGY (2013)
Endometriosis: hormone regulation and clinical consequences of chemotaxis and apoptosis
Fernando M. Reis et al.
HUMAN REPRODUCTION UPDATE (2013)
Ovarian cancers arising from endometriosis: A microenvironmental biomarker study including ER, HNF1β, p53, PTEN, BAF250a, and COX-2
Chiung-Ru Lai et al.
JOURNAL OF THE CHINESE MEDICAL ASSOCIATION (2013)
Cancer risk and PCOS
Daniel A. Dumesic et al.
STEROIDS (2013)
Hereditary gynecological tumors associated with Peutz-Jeghers syndrome
Kouji Banno et al.
ONCOLOGY LETTERS (2013)
Insulin Resistance and the Polycystic Ovary Syndrome Revisited: An Update on Mechanisms and Implications
Evanthia Diamanti-Kandarakis et al.
ENDOCRINE REVIEWS (2012)
Proteomic biomarkers for ovarian cancer risk in women with polycystic ovary syndrome: a systematic review and biomarker database integration
Nicolas Galazis et al.
FERTILITY AND STERILITY (2012)
The association between endometriosis and ovarian cancer: A review of histological, genetic and molecular alterations
Peter Svenssen Munksgaard et al.
GYNECOLOGIC ONCOLOGY (2012)
Pro12Ala PPARγ2 gene polymorphism in PCOS women: the role of compounds regulating satiety
Bozena Bidzinska-Speichert et al.
GYNECOLOGICAL ENDOCRINOLOGY (2012)
Endometrial miR-200c is Altered During Transformation into Cancerous States and Targets the Expression of ZEBs, VEGFA, FLT1, IKKβ, KLF9, and FBLN5
Harekrushna Panda et al.
REPRODUCTIVE SCIENCES (2012)
Regulation of chromatin by histone modifications
Andrew J. Bannister et al.
CELL RESEARCH (2011)
Aromatase inhibitors for ovulation induction and ovarian stimulation
Vivian Chi Yan Lee et al.
CLINICAL ENDOCRINOLOGY (2011)
Molecular pathogenesis and extraovarian origin of epithelial ovarian cancer-Shifting the paradigm
Robert J. Kurman et al.
HUMAN PATHOLOGY (2011)
Epigenetic Regulation of Cancer-Associated Genes in Ovarian Cancer
Mi Jeong Kwon et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2011)
PIK3CA mutation is an early event in the development of endometriosis-associated ovarian clear cell adenocarcinoma
Sohei Yamamoto et al.
JOURNAL OF PATHOLOGY (2011)
Integrated genomic analyses of ovarian carcinoma
D. Bell et al.
NATURE (2011)
The FOXL2 C134W mutation is characteristic of adult granulosa cell tumors of the ovary
Stacey Jamieson et al.
MODERN PATHOLOGY (2010)
Altered Gene Expression Profiling in Endometrium: Evidence for Progesterone Resistance
Lusine Aghajanova et al.
SEMINARS IN REPRODUCTIVE MEDICINE (2010)
Defining the proliferative phase endometrial defect
Jason G. Bromer et al.
FERTILITY AND STERILITY (2009)
MicroRNA-Regulated Pathways Associated with Endometriosis
E. Maria C. Ohlsson Teague et al.
MOLECULAR ENDOCRINOLOGY (2009)
Mutation of FOXL2 in Granulosa-Cell Tumors of the Ovary
Sohrab P. Shah et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Share Paper
